| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/29/2005 | US20050214890 Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof |
| 09/29/2005 | US20050214888 Using animal models to isentify modulators of cAMP responsive element binding protein (CREB) activity; for treatment and prevention of brain and cell proliferative disorders; antisense agents; antitumor agents |
| 09/29/2005 | US20050214886 Using intracellular domain of tumor necrosis factor as screening tool in detection of modulators for treatment of inflammation, sepsis, rheumatic and eating disorders |
| 09/29/2005 | US20050214869 Molecular interactions in hematopoietic cells |
| 09/29/2005 | US20050214867 Prion protein standard and method of making same |
| 09/29/2005 | US20050214864 NPHP nucleic acids and proteins |
| 09/29/2005 | US20050214861 Human hematopoietic stem and progenitor antigen and methods for its use |
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214858 Nucleotide sequences coding liver protein for identifying modulators for prevention and treatment diabetes |
| 09/29/2005 | US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 09/29/2005 | US20050214850 Sitosterolemia susceptibility gene (SSG): compositions and methods of use |
| 09/29/2005 | US20050214848 Reagents and methods useful for detecting diseases of the breast |
| 09/29/2005 | US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/29/2005 | US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders |
| 09/29/2005 | US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof |
| 09/29/2005 | US20050214835 Diagnosis and treatment of myocardial failure |
| 09/29/2005 | US20050214830 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214829 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 09/29/2005 | US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics |
| 09/29/2005 | US20050214822 Using cypin in assays, diagnostics and treatment of cognitive disorders |
| 09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214813 Amyloid-beta protein aggregation-regulating factors |
| 09/29/2005 | US20050214802 screening inhibitors of caspase interaction with a melanoma-inhibitor of apoptosis (ML-IAP) chimera; diagnosing cancer |
| 09/29/2005 | US20050214801 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 09/29/2005 | US20050214800 Human zven proteins |
| 09/29/2005 | US20050214798 Bridging integrator-2 (Bin2) nucleic acid molecules and proteins and uses therefor |
| 09/29/2005 | US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents |
| 09/29/2005 | US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome |
| 09/29/2005 | US20050214793 Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1 |
| 09/29/2005 | US20050214791 Therappeutic polypeptide for treatment of metabolic disorders |
| 09/29/2005 | US20050214790 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of schizophrenia |
| 09/29/2005 | US20050214787 Also probe consisting of the nucleic acid molecule, a reporter molecule (particularly a fluorophore), and a quencher molecule; used especially in hybridization assays and TaqMan (reg) based assays |
| 09/29/2005 | US20050214786 26 human secreted proteins |
| 09/29/2005 | US20050214781 Ovarian specific nucleic acid (OSNA) for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; genetic vaccines |
| 09/29/2005 | US20050214776 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits |
| 09/29/2005 | US20050214773 Recombinant UDP-N-acetylmuramoylalanine-D-glutamate ligase for use as tool in identifying modulators which prevent microbial infection; bactericides |
| 09/29/2005 | US20050214771 Methods for identifying risk of breast cancer and treatments thereof |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214757 Diagnosis and therapy of conditions by detection or modulation of the alms1 gene or protein |
| 09/29/2005 | US20050214756 Cell visual characteristic-modifying sequences |
| 09/29/2005 | US20050214754 Process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 09/29/2005 | US20050214742 Screen for CDC7 inhibitors |
| 09/29/2005 | US20050214741 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
| 09/29/2005 | US20050214739 Expression of G protein coupled receptors in yeast |
| 09/29/2005 | US20050214738 Animal models comprising rapamycin binding (FRB) domain and target of rapamycin (TOR) sequence for use in identifying modulators of cellular pathways |
| 09/29/2005 | US20050214346 For reducing serum cholesterol by increasing high density lipoprotein concentration; hypercholesterolemia |
| 09/29/2005 | US20050214321 Recombinant icosahedral virus like particle production in pseudomonads |
| 09/29/2005 | US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus |
| 09/29/2005 | US20050214319 Peptides and DNA encoding peptides that carry novel cytotoxic T lymphocyte epitopes derived from fragments of human immunodeficiency virus-1 Pol or envelope proteins and carry HLA-A*1101 binding motif; vaccines |
| 09/29/2005 | US20050214318 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 09/29/2005 | US20050214317 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 09/29/2005 | US20050214316 Generating and sequencing an infectious bursal disease virus cDNA from sample suspected of having a strain of IBDV, aligning the sequence with one or more IBDV sequences, and comparing relatedness of aligned IBDV sequences; selecting a vaccine for chickens, ducks, geese, pheasants, quail and turkeys. |
| 09/29/2005 | US20050214315 Antibodies to human IL-17F and other CTLA-8-related proteins and methods related thereto |
| 09/29/2005 | US20050214314 Human cytokine receptor |
| 09/29/2005 | US20050214313 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease |
| 09/29/2005 | US20050214312 Heat shock protein-based vaccines and immunotherapies |
| 09/29/2005 | US20050214311 Immunocomplex of an antigen, especially a tumor-associated antigen, bacterial or viral antigen, and Fas ligand as an adjuvant; fusion protein; nucleic acid; treating cancer |
| 09/29/2005 | US20050214309 Methods and compositions for modulating transcription factor activity |
| 09/29/2005 | US20050214308 by administering a STIgMA polypeptide or its agonist; autoimmune, respiratory, kidney, skin, cardiovascular disorders, hepatitis |
| 09/29/2005 | US20050214306 Surface proteins of leptospira |
| 09/29/2005 | US20050214305 VEGI, an inhibitor of angiogenesis and tumor growth |
| 09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
| 09/29/2005 | US20050214290 Methods of blocking tissue destruction by autoreactive T cells |
| 09/29/2005 | US20050214284 Soluble TCR molecules and methods of use |
| 09/29/2005 | US20050214282 Expressed genes that define the osteoclast phenotype |
| 09/29/2005 | US20050214281 G-protein coupled receptor |
| 09/29/2005 | US20050214267 Compositions and methods for controlling insects related to the octopamine receptor |
| 09/29/2005 | US20050214264 Engineered to include recombinant lytic factor; evades host immune system; high capacity, target cell specificity; genes and nonnucleic acid materials |
| 09/29/2005 | US20050214258 Vectors for delivering viral and oncogenic inhibitors |
| 09/29/2005 | US20050214256 Expression cassette generated from these sequences; generating an immune response in a subject |
| 09/29/2005 | US20050214255 N-acylated chitinous polymers and methods of use thereof |
| 09/29/2005 | US20050214254 growth hormone supergene family; prolongs circulating half-lives of protein therapeutics in the body so proteins do not have to be injected frequently; adding cysteine residues to non-essential regions using site-directed mutagenesis; covalently coupling a cysteine-reactive polymer via the added cysteine |
| 09/29/2005 | US20050214253 Interferon-beta fusion proteins and uses |
| 09/29/2005 | US20050214252 Chordin-like molecules and uses thereof |
| 09/29/2005 | US20050214218 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 09/29/2005 | US20050214213 Cone snail peptides |
| 09/29/2005 | US20050214211 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
| 09/29/2005 | DE102004011663A1 Erythropoietin-Flüssigformulierung Erythropoietin liquid formulation |
| 09/29/2005 | DE102004011564A1 Impfstoff zur Vorbeugung und/oder Behandlung einer Herpes-Virus Infektion A vaccine for the prevention and / or treatment of a herpes viral infection |
| 09/29/2005 | CA2843966A1 Follicle stimulating hormone superagonists |
| 09/29/2005 | CA2795418A1 Improved bacterial host cell for the direct expression of peptides |
| 09/29/2005 | CA2563345A1 Follicle stimulating hormone superagonists |
| 09/29/2005 | CA2560636A1 Glycosylation variants of ricin-like proteins |
| 09/29/2005 | CA2560581A1 Pluripotent stem cell growing method |
| 09/29/2005 | CA2560551A1 Transgenic model for alzheimer's disease |
| 09/29/2005 | CA2560525A1 Immunosuppressive cytokine |
| 09/29/2005 | CA2560259A1 Methods for increasing protein polyethylene glycol (peg) conjugation |
| 09/29/2005 | CA2560242A1 Human obesity susceptibility genes encoding peptide hormones and uses thereof |
| 09/29/2005 | CA2560220A1 Genetically modified plants expressing p1b-type atpase of the zn+2/co+2/cd+2/pb+2 subclass and their applications in phytoremediation |
| 09/29/2005 | CA2560185A1 Novel assay for the separation and quantification of hemagglutinin antigens |
| 09/29/2005 | CA2560174A1 Y4 selective receptor agonists for therapeutic interventions |
| 09/29/2005 | CA2560166A1 Y2/y4 selective receptor agonists for therapeutic interventions |
| 09/29/2005 | CA2559838A1 Y2 selective receptor agonists for therapeutic interventions |
| 09/29/2005 | CA2559662A1 Novel antibiotic alternatives |
| 09/29/2005 | CA2559235A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof and therapeutic uses thereof |
| 09/29/2005 | CA2559215A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 09/29/2005 | CA2558371A1 Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 09/29/2005 | CA2557844A1 Infectious bursal disease virus antigenic isolates and vaccines |